MicroRNA 122 (miR-122): Function & Significance
MicroRNA 122 (miR-122) is a liver-specific, non-coding RNA that plays a central role in regulating liver metabolism, viral replication, and the development of liver diseases.
Things worth knowing about "MicroRNA 122"
MicroRNA 122 (miR-122) is a liver-specific, non-coding RNA that plays a central role in regulating liver metabolism, viral replication, and the development of liver diseases.
What is MicroRNA 122?
MicroRNA 122 (abbreviated: miR-122) is a small, non-coding ribonucleic acid (RNA) approximately 22 nucleotides in length. It belongs to the class of microRNAs (miRNAs), which act as post-transcriptional regulators -- meaning they influence gene expression after genetic information has been transcribed from DNA into messenger RNA (mRNA). MicroRNA 122 is produced almost exclusively in liver cells (hepatocytes), where it accounts for up to 70 percent of all miRNAs. This makes it one of the most extensively studied and biologically significant members of its class.
Biological Functions
miR-122 fulfils a wide range of functions in the human body, primarily related to liver metabolism:
- Lipid metabolism regulation: miR-122 controls numerous genes involved in the synthesis of cholesterol and fatty acids. Altered miR-122 activity can lead to lipid metabolism disorders.
- Glucose metabolism: It influences blood sugar regulation through its effects on liver-dependent metabolic pathways.
- Maintenance of hepatocyte identity: miR-122 is essential for liver cells to retain their characteristic properties and functions.
- Support of hepatitis C virus replication: In a unique biological role, miR-122 binds directly to the hepatitis C virus (HCV) and promotes its replication in the liver -- making it an important therapeutic target in hepatitis C treatment.
Relevance in Liver Diseases
Alterations in miR-122 expression have been described in various liver conditions:
Non-Alcoholic Fatty Liver Disease (NAFLD)
In non-alcoholic fatty liver disease (NAFLD) and its advanced form, non-alcoholic steatohepatitis (NASH), miR-122 activity is frequently altered. Elevated miR-122 levels in the blood can indicate hepatocyte injury, as miR-122 is released into the bloodstream when liver cells are damaged or destroyed.
Liver Cancer (Hepatocellular Carcinoma)
In hepatocellular carcinoma (HCC), the most common primary liver cancer, miR-122 is often significantly downregulated. Since miR-122 normally suppresses tumor growth (tumor suppressor function), its loss promotes the uncontrolled proliferation of liver cells and thus tumor development.
Hepatitis B and C
In hepatitis C, miR-122 acts as a so-called host factor: it binds directly to the RNA of the hepatitis C virus and stabilizes it, thereby promoting viral replication. Targeted inhibition of miR-122 using the drug Miravirsen (also known as RG-101) has been investigated in clinical trials as an antiviral approach. In hepatitis B, miR-122 appears to have an inhibitory effect on viral replication.
Alcoholic Liver Disease
In alcohol-related liver injury, miR-122 levels in the blood are also elevated, further supporting its role as a biomarker for acute hepatocellular damage.
miR-122 as a Biomarker
An important clinical application of miR-122 is its use as a biomarker for liver cell injury. Unlike classical liver enzymes such as ALT (alanine aminotransferase) and AST (aspartate aminotransferase), miR-122 is considered highly liver-specific. Studies show that serum miR-122 levels rise very early after hepatocellular damage, enabling earlier diagnosis. Potential applications include:
- Early detection of drug-induced liver toxicity (e.g., paracetamol overdose)
- Monitoring treatment response in liver diseases
- Risk stratification in patients with hepatic conditions
Therapeutic Approaches
Due to its central role in various diseases, miR-122 is considered an attractive therapeutic target. Two main strategies are being pursued:
- Inhibition of miR-122 (antagomirs): Synthetic counterparts (antagomirs or anti-miRs) can block the function of miR-122. This approach has been used in hepatitis C to suppress viral replication.
- Restoration of miR-122 (miRNA replacement therapy): In liver cancer, where miR-122 is downregulated, researchers are investigating whether artificially restoring miR-122 levels can inhibit tumor growth.
References
- Jopling, C.L. et al. (2005): Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science, 309(5740), 1577-1581.
- Tsai, W.C. et al. (2012): MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. Journal of Clinical Investigation, 122(8), 2884-2897.
- Beg, M.S. et al. (2017): Phase I study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. British Journal of Cancer, 116(8), 998-1004. [Reference context: miRNA-based therapies in oncology]
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.